These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3617056)
1. Clinical, biochemical and enzymatic studies in type I hyperprolinemia associated with chromosomal abnormality. Oyanagi K; Tsuchiyama A; Itakura Y; Tamura Y; Nakao T; Fujita S; Shiono H Tohoku J Exp Med; 1987 Apr; 151(4):465-75. PubMed ID: 3617056 [TBL] [Abstract][Full Text] [Related]
2. [A case of type I hyperprolinemia associated with photogenic epilepsy]. Ishikawa Y; Kameda K; Okabe M; Imai T; Nagaoka M; Minami R No To Hattatsu; 1991 Jan; 23(1):81-6. PubMed ID: 1994998 [TBL] [Abstract][Full Text] [Related]
3. Biochemical, morphological and hybrid studies in hyperprolinemic mice. Kanwar YS; Krakower CA; Manaligod JR; Justice P; Wong PW Biomedicine; 1975 May; 22(3):209-16. PubMed ID: 240452 [TBL] [Abstract][Full Text] [Related]
7. Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome. Clelland CL; Read LL; Baraldi AN; Bart CP; Pappas CA; Panek LJ; Nadrich RH; Clelland JD Schizophr Res; 2011 Sep; 131(1-3):139-45. PubMed ID: 21645996 [TBL] [Abstract][Full Text] [Related]
8. Identification of PRODH mutations in Korean neonates with type I hyperprolinemia. Jang MA; Kim BC; Ki CS; Lee SY; Kim JW; Choi TY; Lee DH; Song J; Lee YW; Park HD Ann Clin Lab Sci; 2013; 43(1):31-6. PubMed ID: 23462603 [TBL] [Abstract][Full Text] [Related]
9. Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver. Ferreira AG; da Cunha AA; Machado FR; Pederzolli CD; Dalazen GR; de Assis AM; Lamers ML; dos Santos MF; Dutra-Filho CS; Wyse AT J Cell Biochem; 2012 Jan; 113(1):174-83. PubMed ID: 21882227 [TBL] [Abstract][Full Text] [Related]
11. The severe form of type I hyperprolinaemia results from homozygous inactivation of the PRODH gene. Jacquet H; Berthelot J; Bonnemains C; Simard G; Saugier-Veber P; Raux G; Campion D; Bonneau D; Frebourg T J Med Genet; 2003 Jan; 40(1):e7. PubMed ID: 12525555 [No Abstract] [Full Text] [Related]
12. Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia. van de Ven S; Gardeitchik T; Kouwenberg D; Kluijtmans L; Wevers R; Morava E J Inherit Metab Dis; 2014 May; 37(3):383-90. PubMed ID: 24173411 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association. Clelland JD; Read LL; Drouet V; Kaon A; Kelly A; Duff KE; Nadrich RH; Rajparia A; Clelland CL Schizophr Res; 2014 Jun; 156(1):15-22. PubMed ID: 24787057 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and clinical features of hereditary hyperprolinemia. Mitsubuchi H; Nakamura K; Matsumoto S; Endo F Pediatr Int; 2014 Aug; 56(4):492-6. PubMed ID: 24931297 [TBL] [Abstract][Full Text] [Related]
15. Type I hyperprolinemia. Shivananda ; Christopher R; Kumar P Indian J Pediatr; 2000 Jul; 67(7):541-3. PubMed ID: 10957843 [TBL] [Abstract][Full Text] [Related]
16. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. Goodman BK; Rutberg J; Lin WW; Pulver AE; Thomas GH J Inherit Metab Dis; 2000 Dec; 23(8):847-8. PubMed ID: 11196113 [No Abstract] [Full Text] [Related]
17. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. Di Rosa G; Pustorino G; Spano M; Campion D; Calabrò M; Aguennouz M; Caccamo D; Legallic S; Sgro DL; Bonsignore M; Tortorella G Psychiatr Genet; 2008 Feb; 18(1):40-2. PubMed ID: 18197084 [TBL] [Abstract][Full Text] [Related]
18. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275 [TBL] [Abstract][Full Text] [Related]
19. Long-term neuropsychiatric follow-up in hyperprolinemia type I. Di Rosa G; Nicotera AG; Lenzo P; Spanò M; Tortorella G Psychiatr Genet; 2014 Aug; 24(4):172-5. PubMed ID: 24842239 [TBL] [Abstract][Full Text] [Related]
20. Hyperprolinemia induces DNA, protein and lipid damage in blood of rats: antioxidant protection. Ferreira AG; Scherer EB; da Cunha AA; Manfredini V; Biancini GB; Vanzin CS; Vargas CR; Wyse AT Int J Biochem Cell Biol; 2014 Sep; 54():20-5. PubMed ID: 24980685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]